Ono Pharmaceutical Co., Ltd.
OTC: OPHLY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Gyo Sagara
- Employees
- 3,853
- Headquarters
- Osaka, Japan
- IPO year
- 2012
- Market cap
- $6.7B
- Website
- https://www.ono-pharma.com
Loading OPHLY…
Loading profile data…Frequently asked questions about OPHLY
What does Ono Pharmaceutical Co., Ltd. (OPHLY) do?
Ono Pharmaceutical Co., Ltd., along with its subsidiaries, operates globally, engaging in the research, development, procurement, and commercialization of pharmaceutical products and diagnostic reagents. Its current portfolio features a range of established treatments, notably in oncology, with products such as the intravenous infusions OPDIVO a...
Where does OPHLY trade?
Ono Pharmaceutical Co., Ltd. (OPHLY) trades on the Other OTC.
What sector is OPHLY in?
Ono Pharmaceutical Co., Ltd. (OPHLY) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Ono Pharmaceutical Co., Ltd.?
Gyo Sagara is the chief executive officer of Ono Pharmaceutical Co., Ltd. (OPHLY).
Where is Ono Pharmaceutical Co., Ltd. headquartered?
Ono Pharmaceutical Co., Ltd. is headquartered in Japan.
Does OPHLY pay a dividend?
Yes — Ono Pharmaceutical Co., Ltd. (OPHLY) paid a trailing twelve-month dividend of USD 0.17 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did OPHLY go public?
Ono Pharmaceutical Co., Ltd. (OPHLY) completed its initial public offering in 2012.
Is OPHLY an ADR?
Yes — OPHLY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Ono Pharmaceutical Co., Ltd. reporting and dividends follow the underlying issuer.